CareDx appoints John W. Hanna as President and CEO effective April 15, 2024

CareDx, Inc.

John Hanna appointed CEO and Class III director, effective April 15, 2024.
Annual base salary of $675,000; eligible for annual bonus up to 100% of salary.
Received inducement options and RSUs each valued at $4M, vesting over four years.
Previously CEO of Apton Biosystems and CCO at Veracyte for ten years.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John W. Hanna

Class III director

CDNA · CareDx, Inc.

Effective: 2024-04-15
Filed: April 16, 2024, 7:59 PM ET

The Board of Directors (the “Board”) of CareDx, Inc. (the “Company”) has appointed John W. Hanna as the Company’s President and Chief Executive Officer and as a Class III director of the Company, in each case effective April 15, 2024 (the “Effective Date”).

Appointed

John W. Hanna

President and Chief Executive Officer

CDNA · CareDx, Inc.

Effective: 2024-04-15
Filed: April 16, 2024, 7:59 PM ET

The Board of Directors (the “Board”) of CareDx, Inc. (the “Company”) has appointed John W. Hanna as the Company’s President and Chief Executive Officer and as a Class III director of the Company, in each case effective April 15, 2024 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John W. Hanna was appointed as Class III director at CareDx, Inc..

Action: appointed
Role: Class III director

Exact text from the filing

The Board of Directors (the “Board”) of CareDx, Inc. (the “Company”) has appointed John W. Hanna as the Company’s President and Chief Executive Officer and as a Class III director of the Company, in each case effective April 15, 2024 (the “Effective Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

John W. Hanna was appointed as President and Chief Executive Officer at CareDx, Inc..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

The Board of Directors (the “Board”) of CareDx, Inc. (the “Company”) has appointed John W. Hanna as the Company’s President and Chief Executive Officer and as a Class III director of the Company, in each case effective April 15, 2024 (the “Effective Date”).

View on SEC.gov

CareDx, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-097776

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.